Cellia Science, Inc. was founded in 2021 to bring rapid, accurate blood cell assays out of the lab and into the clinic. The label-free technology is suitable for point-of-care settings and will enable high quality visualization and accurate quantitative measurement of all blood cell types.
Cellia’s first device will perform 5-part white blood cell differentials and platelet counts. Currently, these results may take hours or days to receive. Cellia’s technology will bring the testing to the patients, enabling results in minutes!
Cellia’s first device will perform 5-part white blood cell differentials and platelet counts. Currently, these results may take hours or days to receive. Cellia’s technology will bring the testing to the patients, enabling results in minutes!
Investors 1
| Date | Name | Website |
| - | VIC Techno... | victech.co... |
Mentions in press and media 2
| Date | Title | Description |
| 20.04.2022 | Cellia Science Formed to Develop and Commercialization Point-of-Care Hematology Analyzers | “Because our technology appears to achieve fast, reliable, quantitative, and simple blood cell analysis in a low-cost configuration,” said Dr. Robles, CSO “it has great potential to simplify and improve clinical hematological analysis.” FAY... |
| - | Cellia Science | “celliasci.com – Point of Care When You Need It Most” |